Current Report Filing (8-k)
August 05 2021 - 06:51AM
Edgar (US Regulatory)
0001725255 false 0001725255 2021-08-05
2021-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported):
August 5, 2021
AdaptHealth Corp.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
001-38399 |
|
82-3677704 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
220 West Germantown Pike,
Suite 250
Plymouth Meeting,
PA
|
|
19462 |
|
(Address of
principal executive offices) |
|
(Zip
Code) |
| |
|
|
|
(610)
630-6357 |
|
(Registrant’s telephone
number, including area code)
|
|
Not
Applicable
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.0001 per share |
AHCO |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the
extended transition period for complying with any new or revised
financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act.
Item 2.02. Results of Operations and Financial
Condition.
The following information is furnished pursuant to Regulation
FD.
On August 5, 2021, AdaptHealth Corp. (the “Company”) issued a
press release (the “Press Release”) announcing financial results
for the three and six months ended June 30, 2021. A copy of
the Press Release is furnished herewith as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated herein by
reference.
The information in this Item 2.02 (including Exhibit 99.1)
shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that section, nor shall
it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended (the “Securities Act”), or the
Exchange Act, regardless of any general incorporation language in
such filing, unless expressly incorporated by reference in such
filing.
Item 9.01. Financial Statements and Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, hereunto duly authorized.
Dated: August 5, 2021
| |
AdaptHealth
Corp. |
| |
|
| |
|
| |
By: |
/s/ Jason
Clemens |
| |
|
Name: Jason
Clemens |
| |
|
Title: Chief Financial
Officer |
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Jan 2023 to Feb 2023
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Feb 2022 to Feb 2023
